Article ; Online: Characteristics and outcomes of patients hospitalized for COVID-19 in France: The Critical COVID-19 France (CCF) study.
Archives of cardiovascular diseases
2021 Volume 114, Issue 5, Page(s) 352–363
Abstract: ... of patients hospitalized for COVID-19 in France.: Methods: The Critical COVID-19 France (CCF) study is ... Conclusions: In this large nationwide cohort of patients hospitalized for COVID-19 in France, cardiovascular ... Only limited data are available on the characteristics and outcomes of patients hospitalized for COVID ...
| Abstract | Background: The coronavirus disease 2019 (COVID-19) pandemic has led to a public health crisis. Only limited data are available on the characteristics and outcomes of patients hospitalized for COVID-19 in France. Aims: To investigate the characteristics, cardiovascular complications and outcomes of patients hospitalized for COVID-19 in France. Methods: The Critical COVID-19 France (CCF) study is a French nationwide study including all consecutive adults with a diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection hospitalized in 24 centres between 26 February and 20 April 2020. Patients admitted directly to intensive care were excluded. Clinical, biological and imaging parameters were systematically collected at hospital admission. The primary outcome was in-hospital death. Results: Of 2878 patients included (mean±SD age 66.6±17.0 years, 57.8% men), 360 (12.5%) died in the hospital setting, of which 7 (20.7%) were transferred to intensive care before death. The majority of patients had at least one (72.6%) or two (41.6%) cardiovascular risk factors, mostly hypertension (50.8%), obesity (30.3%), dyslipidaemia (28.0%) and diabetes (23.7%). In multivariable analysis, older age (hazard ratio [HR] 1.05, 95% confidence interval [CI] 1.03-1.06; P<0.001), male sex (HR 1.69, 95% CI 1.11-2.57; P=0.01), diabetes (HR 1.72, 95% CI 1.12-2.63; P=0.01), chronic kidney failure (HR 1.57, 95% CI 1.02-2.41; P=0.04), elevated troponin (HR 1.66, 95% CI 1.11-2.49; P=0.01), elevated B-type natriuretic peptide or N-terminal pro-B-type natriuretic peptide (HR 1.69, 95% CI 1.0004-2.86; P=0.049) and quick Sequential Organ Failure Assessment score ≥2 (HR 1.71, 95% CI 1.12-2.60; P=0.01) were independently associated with in-hospital death. Conclusions: In this large nationwide cohort of patients hospitalized for COVID-19 in France, cardiovascular comorbidities and risk factors were associated with a substantial morbi-mortality burden. |
|---|---|
| MeSH term(s) | Adult ; Aged ; Aged, 80 and over ; COVID-19/epidemiology ; COVID-19/therapy ; Cardiovascular Diseases/epidemiology ; Comorbidity ; Diabetes Mellitus/epidemiology ; Dyslipidemias/epidemiology ; Female ; France/epidemiology ; Hospital Mortality ; Humans ; Hypertension/epidemiology ; Inpatients/statistics & numerical data ; Intensive Care Units/statistics & numerical data ; Kidney Failure, Chronic/epidemiology ; Male ; Middle Aged ; Obesity/epidemiology ; Pandemics ; Risk Factors ; SARS-CoV-2 ; Treatment Outcome |
| Language | English |
| Publishing date | 2021-03-02 |
| Publishing country | Netherlands |
| Document type | Comparative Study ; Journal Article ; Multicenter Study ; Observational Study |
| ZDB-ID | 2408778-6 |
| ISSN | 1875-2128 ; 1875-2136 |
| ISSN (online) | 1875-2128 |
| ISSN | 1875-2136 |
| DOI | 10.1016/j.acvd.2021.01.003 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Ui IV Zs 8: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.